MedPath

Study on the effect of Pengs Spermatogenic prescription on asthenospermia of male with kidney yang deficiency and failure

Not Applicable
Conditions
Male asthenospermia
Registration Number
ITMCTR2000003116
Lead Sponsor
Shanghai Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

1. Male patients aged between 23 (inclusive) and 40 (inclusive) years;
2. Patients who meet the above diagnostic criteria of Western Medicine;
3. Patients who meet the above criteria of TCM dialectical classification;
4. The subjects voluntarily participate in the clinical trial and sign the informed consent;
5. Patients who have not taken the internal medicine related to the disease within 30 days before treatment and have not used the external medicine related to the disease within 7 days.
Those who meet the above five criteria can be included in the test cases.

Exclusion Criteria

1. With azoospermia; Reverse discharge;
2. Taking anti-epileptic, anti-tumor and other drugs that hinder sperm production and sperm motility;
3. Congenital malformation, sperm obstruction, testicular atrophy; Immune sterility and varicocele; Orchitis, epididymitis, moderate to severe prostatitis;
4. Having a history of reproductive organ surgery or trauma and affecting reproductive function;
5. Combined with cardiovascular, liver, kidney, hematopoietic system, endocrine and immune, genetic diseases, mental patients.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Kidney function;Gonadotropin levels;Semen routine;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath